Clinical Trials Directory

Trials / Unknown

UnknownNCT03456232

High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Guangdong Provincial People's Hospital · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Accepted

Summary

This study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on small and moderate molecule substances clearance. Meanwhile, this study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on cardiac function. In this self matching study, participants will receive high-flux hemodialysis compared to hemodiafiltration.

Detailed description

Hemodialysis using diffusion, ultrafiltration and convection principle to remove harmful substances in the blood and excessive water, is one of the most commonly replacement therapy. Hemodiafiltration is a combination of hemodialysis and hemofiltration with two modes of treatment advantages, both by diffusion and convection principle to remove harmful substances in the blood.

Conditions

Interventions

TypeNameDescription
OTHERHigh-flux hemodialysisHigh-flux hemodialysis using diffusion, ultrafiltration and convection principle to remove harmful substances in the blood and excessive water.
OTHERHemodiafiltrationHemodiafiltration is a combination of hemodialysis and hemofiltration with two modes of treatment advantages, both by diffusion and convection principle to remove harmful substances in the blood.

Timeline

Start date
2017-12-21
Primary completion
2018-03-10
Completion
2018-03-20
First posted
2018-03-07
Last updated
2018-03-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03456232. Inclusion in this directory is not an endorsement.